[HTML][HTML] Leveraging SARS-CoV-2 Main Protease (Mpro) for COVID-19 Mitigation with Selenium-Based Inhibitors
The implementation of innovative approaches is crucial in an ongoing endeavor to mitigate
the impact of COVID-19 pandemic. The present study examines the strategic application of …
the impact of COVID-19 pandemic. The present study examines the strategic application of …
A Short Update on the Use of Monoclonal Antibodies in COVID-19
A Vitiello, M Sabbatucci, A Ponzo, A Salzano, A Zovi - The AAPS Journal, 2024 - Springer
Monoclonal antibodies in the prophylaxis and treatment of COVID-19 have been crucial in
reducing severe infections when vaccines were unavailable. However, as the virus and its …
reducing severe infections when vaccines were unavailable. However, as the virus and its …
[HTML][HTML] Adverse Events Associated With COVID-19 Pharmaceutical Treatments
M Maglione, JD Klausner, PK Wirnkar, I Fallarme… - 2024 - ncbi.nlm.nih.gov
Background and Purpose The purpose of this rapid review is to determine if COVID
treatments authorized for emergency use by the Food and Drug Administration (FDA) are …
treatments authorized for emergency use by the Food and Drug Administration (FDA) are …
[HTML][HTML] Welcome Guest United States
MS Long - biocompare.com
Monoclonal antibodies (mAbs) are classic examples of personalized diagnostics and
therapeutics (Malik and Ghatol, 2021). They bind specifically to nearly any therapeutically …
therapeutics (Malik and Ghatol, 2021). They bind specifically to nearly any therapeutically …